Venomous snakebites worldwide with a focus on the Australia-Pacific region

Current management and controversies

Allen C. Cheng, Bart J Currie

Research output: Contribution to journalReview ArticleResearchpeer-review

30 Citations (Scopus)

Abstract

Snakebites are estimated to cause approximately 100,000 deaths each year worldwide and disproportionately affect rural populations in resource-poor settings. Snake venoms may produce local tissue damage and/or distinct clinical syndromes, including neurotoxicity, coagulopathy, hypotension, rhabdomyolysis, and renal failure. Field management is aimed at delaying systemic absorption of toxins, minimizing local damage and infection, and expediting transport to medical facilities. The use of the pressureimmobilization method remains controversial. The use of antivenom, administered in a timely fashion and in adequate doses, is the mainstay of hospital treatment of significant envenomation. The availability, efficacy, and safety of antivenoms vary throughout the world, with a current crisis in antivenom supplies.

Original languageEnglish
Pages (from-to)259-269
Number of pages11
JournalJournal of Intensive Care Medicine
Volume19
Issue number5
DOIs
Publication statusPublished - Sep 2004
Externally publishedYes

Keywords

  • Antivenins
  • Antivenoms
  • Blood coagulation disorders
  • Developing countries
  • Neurotoxins
  • Snakebites

Cite this

@article{4524bdc260cc4e54ba242af19e2506f5,
title = "Venomous snakebites worldwide with a focus on the Australia-Pacific region: Current management and controversies",
abstract = "Snakebites are estimated to cause approximately 100,000 deaths each year worldwide and disproportionately affect rural populations in resource-poor settings. Snake venoms may produce local tissue damage and/or distinct clinical syndromes, including neurotoxicity, coagulopathy, hypotension, rhabdomyolysis, and renal failure. Field management is aimed at delaying systemic absorption of toxins, minimizing local damage and infection, and expediting transport to medical facilities. The use of the pressureimmobilization method remains controversial. The use of antivenom, administered in a timely fashion and in adequate doses, is the mainstay of hospital treatment of significant envenomation. The availability, efficacy, and safety of antivenoms vary throughout the world, with a current crisis in antivenom supplies.",
keywords = "Antivenins, Antivenoms, Blood coagulation disorders, Developing countries, Neurotoxins, Snakebites",
author = "Cheng, {Allen C.} and Currie, {Bart J}",
year = "2004",
month = "9",
doi = "10.1177/0885066604265799",
language = "English",
volume = "19",
pages = "259--269",
journal = "Journal of Intensive Care Medicine",
issn = "0885-0666",
publisher = "Wiley-Blackwell",
number = "5",

}

Venomous snakebites worldwide with a focus on the Australia-Pacific region : Current management and controversies. / Cheng, Allen C.; Currie, Bart J.

In: Journal of Intensive Care Medicine, Vol. 19, No. 5, 09.2004, p. 259-269.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Venomous snakebites worldwide with a focus on the Australia-Pacific region

T2 - Current management and controversies

AU - Cheng, Allen C.

AU - Currie, Bart J

PY - 2004/9

Y1 - 2004/9

N2 - Snakebites are estimated to cause approximately 100,000 deaths each year worldwide and disproportionately affect rural populations in resource-poor settings. Snake venoms may produce local tissue damage and/or distinct clinical syndromes, including neurotoxicity, coagulopathy, hypotension, rhabdomyolysis, and renal failure. Field management is aimed at delaying systemic absorption of toxins, minimizing local damage and infection, and expediting transport to medical facilities. The use of the pressureimmobilization method remains controversial. The use of antivenom, administered in a timely fashion and in adequate doses, is the mainstay of hospital treatment of significant envenomation. The availability, efficacy, and safety of antivenoms vary throughout the world, with a current crisis in antivenom supplies.

AB - Snakebites are estimated to cause approximately 100,000 deaths each year worldwide and disproportionately affect rural populations in resource-poor settings. Snake venoms may produce local tissue damage and/or distinct clinical syndromes, including neurotoxicity, coagulopathy, hypotension, rhabdomyolysis, and renal failure. Field management is aimed at delaying systemic absorption of toxins, minimizing local damage and infection, and expediting transport to medical facilities. The use of the pressureimmobilization method remains controversial. The use of antivenom, administered in a timely fashion and in adequate doses, is the mainstay of hospital treatment of significant envenomation. The availability, efficacy, and safety of antivenoms vary throughout the world, with a current crisis in antivenom supplies.

KW - Antivenins

KW - Antivenoms

KW - Blood coagulation disorders

KW - Developing countries

KW - Neurotoxins

KW - Snakebites

UR - http://www.scopus.com/inward/record.url?scp=16544390601&partnerID=8YFLogxK

U2 - 10.1177/0885066604265799

DO - 10.1177/0885066604265799

M3 - Review Article

VL - 19

SP - 259

EP - 269

JO - Journal of Intensive Care Medicine

JF - Journal of Intensive Care Medicine

SN - 0885-0666

IS - 5

ER -